Molecular pathways linking inflammation and cancer

A Mantovani - Current molecular medicine, 2010 - ingentaconnect.com
Inflammatory conditions in selected organs increase the risk of cancer. An inflammatory
component is present also in the microenvironment of tumours that are not epidemiologically …

International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric …

A Christopoulos, JP Changeux, WA Catterall… - Pharmacological …, 2014 - ASPET
Allosteric interactions play vital roles in metabolic processes and signal transduction and,
more recently, have become the focus of numerous pharmacological studies because of the …

AMD3100 is a CXCR7 ligand with allosteric agonist properties

I Kalatskaya, YA Berchiche, S Gravel, BJ Limberg… - Molecular …, 2009 - ASPET
The bicyclam AMD3100 is known as a small synthetic inhibitor of the CXCL12-binding
chemokine receptor CXCR4. Here, we show that AMD3100 also binds to the alternative …

Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4

MM Mysinger, DR Weiss, JJ Ziarek… - Proceedings of the …, 2012 - National Acad Sciences
G-protein–coupled receptors (GPCRs) are key signaling molecules and are intensely
studied. Whereas GPCRs recognizing small-molecules have been successfully targeted for …

Touch of chemokines

X Blanchet, M Langer, C Weber, RR Koenen… - Frontiers in …, 2012 - frontiersin.org
Chemoattractant cytokines or chemokines constitute a family of structurally related proteins
found in vertebrates, bacteria, or viruses. So far, 48 chemokine genes have been identified …

Anti-chemokine small molecule drugs: a promising future?

AEI Proudfoot, CA Power… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Chemokines have principally been associated with inflammation due
to their role in the control of leukocyte migration, but just over a decade ago chemokine …

Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief

A Moriconi, TM Cunha, GR Souza… - Proceedings of the …, 2014 - National Acad Sciences
Chronic pain resulting from inflammatory and neuropathic disorders causes considerable
economic and social burden. Pharmacological therapies currently available for certain types …

Strategies for the identification of allosteric modulators of G-protein-coupled receptors

NT Burford, J Watson, R Bertekap, A Alt - Biochemical pharmacology, 2011 - Elsevier
Once considered a pharmacological curiosity, allosteric modulation of seven
transmembrane domain G-protein-coupled receptors (GPCRs) has emerged as a potentially …

Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities

M De Amici, C Dallanoce, U Holzgrabe… - Medicinal research …, 2010 - Wiley Online Library
Allosteric receptor ligands bind to a recognition site that is distinct from the binding site of the
endogenous messenger molecule. As a consequence, allosteric agents may attach to …

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 low Mice

P Verachi, F Gobbo, F Martelli, A Martinelli… - Frontiers in …, 2022 - frontiersin.org
A major role for human (h) CXCL8 (interleukin-8) in the pathobiology of myelofibrosis (MF)
has been suggested by observations indicating that MF megakaryocytes express increased …